Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, ME
K. Murray , L. Lucas , S. Miesfeldt
Background: Quality end-of-life cancer care involves a shift from aggressive therapy to supportive services. Reasons for variations in intensity of late-life cancer care are incompletely understood. The goal of this work was to examine intensity of care based on principal healthcare provider in the last month of life, comparing primary care providers (PCPs) with oncology specialists. Methods: A retrospective claims-based analysis of hospitalizations, emergency department (ED) visits, intensive care unit admissions in the last 30 days of life; in-hospital deaths; terminal chemotherapy; and under-use/late hospice referrals among a 20% sample (n=235,821) of Medicare beneficiaries dying with poor-prognosis cancers. Logistic regression was used to quantify care variations comparing PCPs with oncology specialists as well as combined care by PCPs and oncology specialists Results: Among the 235,821 individuals studied, mean age at death was 78 years, 51.4% were male, 90.8% were non-black race, 73.5% lived in urban areas, and median income was $46,634. Of these, 74% received care from a PCP and/or an oncology specialist in the last month of life. Data (expressed as %) comparing the full cohort with those principally cared for by PCPs versus by oncology specialists versus combined care by PCPs and oncology specialists follow. Conclusions: Most measures of care intensity fell outside published benchmarks, signifying overly aggressive care. Intensity of late-life care among cancer-affected seniors varies significantly by principal healthcare provider with the most intensive care shown among those receiving combined care from PCPs and oncology specialists.
All patients | Primary care (PCP) only | Oncology specialist only | PCP and oncology | |
---|---|---|---|---|
n= | 235,821 | 100,766 (42.7%) | 33,318 (14.1%) | 39,554 (16.8%) |
More than 1 hospitalization | 10.2 | 12.4 | 8.5 | 18.3 |
More than 1 ED visit | 10.2 | 13.5 | 6.2 | 17.2 |
Admitted to ICU | 23.7 | 29.2 | 18.1 | 31.3 |
Died in an acute care facility | 28.8 | 30.3 | 31.1 | 37.8 |
Chemotherapy within 14 days of death | 6.0 | 1.6 | 16.4 | 15.9 |
Chemotherapy within 30 days of death | 12.5 | 3.7 | 34.2 | 31.4 |
No hospice services within 6 months of death | 44.8 | 50.6 | 43.2 | 54.6 |
Admitted to hospice within 3 days of death | 15.1 | 18.3 | 17.3 | 27.4 |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2024 ASCO Quality Care Symposium
First Author: Kerin B. Adelson
2021 ASCO Quality Care Symposium
First Author: Laura Donovan
2023 ASCO Annual Meeting
First Author: Amy An
2020 ASCO Virtual Scientific Program
First Author: Cathy Zhang